Showing 1 - 6 results of 6 for search 'Hong-Ming Yu', query time: 0.03s Refine Results
  1. 1
    Comparison of dosimetry between TOMO and VMAT after TURBT for bladder cancer

    Comparison of dosimetry between TOMO and VMAT after TURBT for bladder cancer by LI Hong-ming, YU Lang, LI Rui, SHEN Jie, ZHANG Fu-quan, WU Song

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol

    Efficacy and safety of radiotherapy combined with atezolizumab plus bevacizumab in treating hepatocellular carcinoma with portal vein tumour thrombus: a study protocol by Jie Shi, Kang Wang, Shuang Feng, Hong-Ming Yu, Yan-Jun Xiang, Yu-Qiang Cheng, Qian-Zhi Ni, Wei-Xing Guo, Jian Zhai, Shu-Qun Cheng

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation

    Overall survival of patients with hepatocellular carcinoma treated with sintilimab and disease outcome after treatment discontinuation by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Jin-Kai Feng, Zong-Han Liu, Yun-Feng Shan, Yi-Tao Zheng, Qian-Zhi Ni, Shu-Qun Cheng

    Published 2023-10-01
    Get full text
    Article
  4. 4
    Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study

    Efficacy and safety of TACE combined with lenvatinib and PD‐1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective study by Wei‐Jun Wang, Zong‐Han Liu, Kang Wang, Hong‐Ming Yu, Yu‐Qiang Cheng, Yan‐Jun Xiang, Jin‐Kai Feng, Li‐Ping Zhou, Hong‐Kun Zhou, Wei‐Wei Pan, Wei‐Xing Guo, Jie Shi, Shu‐Qun Cheng

    Published 2023-05-01
    Get full text
    Article
  5. 5
    Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study

    Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective study by Kang Wang, Zong-Han Liu, Hong-Ming Yu, Yu-Qiang Cheng, Yan-Jun Xiang, Jing-Ya Zhong, Qian-Zhi Ni, Li-Ping Zhou, Chao Liang, Hong-Kun Zhou, Wei-Wei Pan, Wei-Xing Guo, Jie Shi, Shu-Qun Cheng

    Published 2023-03-01
    Get full text
    Article
  6. 6
    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A preliminary multicenter single-arm prospective study

    Intensity-modulated radiotherapy combined with systemic atezolizumab and bevacizumab in treatment of hepatocellular carcinoma with extrahepatic portal vein tumor thrombus: A prelim... by Kang Wang, Yan-Jun Xiang, Hong-Ming Yu, Yu-Qiang Cheng, Zong-Han Liu, Jing-Ya Zhong, Shuang Feng, Qian-Zhi Ni, Qian-Zhi Ni, Hong-Fei Zhu, Wei-Wei Pan, Wei-Wei Pan, Jing-Jing Li, Chao Liang, Hong-Kun Zhou, Yan Meng, Wan Yee Lau, Wan Yee Lau, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng, Shu-Qun Cheng

    Published 2023-02-01
    Get full text
    Article

Search Tools: